Researchers say that a daily routine of low-dose aspirin does not appear to reduce the risk of cancer in older adults.

Longer follow-up of the ASPREE cohort is warranted, says researcher ...

In A Nutshell Starting aspirin after age 70 did not prevent cancer in a study of nearly 20,000 older adults followed for ...

A follow-up study suggests that aspirin therapy does not reduce cancer risk in older adults, but may instead increase cancer-related mortality risk.

Prior studies, largely among middle-aged adults, have reported that taking aspirin reduces the risk of cancer after 10 years, ...

New research by Monash University has found that taking daily low-dose aspirin will not reduce long-term cancer risk in older adults.

Low-dose aspirin may limit cancer metastasis by inhibiting platelet activation and enhancing T-cell immunity, supporting biomarker guided use while balancing bleeding risk overall.

Colton Jones, M.D., of The University of Texas San Antonio, discusses aspirin for colorectal cancer prevention after presenting research comparing GLP-1s with aspirin at the 2026 ASCO Gastrointestinal ...

One of aspirin’s most intriguing properties is its anti-cancer activity. A Swedish research study published in the New England Journal of Medicine (Sept. 18, 2025) concludes that aspirin can ...

Aspirin is often touted as the wonder drug of the 20th century. Famous for its versatility—easing aches and pains, reducing fever and inflammation, preventing heart attacks and stroke—experts have ...

The use of GLP-1 receptor antagonist therapy has led to a greater reduction in colorectal cancer incidence than has been ...